Cargando…
Do GnRH Agonists Really Increase Body Weight Gain? Evaluation of a Multicentric Portuguese Cohort of Patients With Central Precocious Puberty
INTRODUCTION: There are several concerns associated with gonadotropin-releasing hormone agonist (GnRHa) treatment for central precocious puberty (CPP), such as obesity and changes in body mass index (BMI). We aimed to investigate whether any anthropometric differences exist and if they persist over...
Autores principales: | Leite, Ana Luísa, Galo, Elisa, Antunes, Ana, Robalo, Brígida, Amaral, Daniela, Espada, Filipa, Castro, Sofia, Simões Dias, Sara, Limbert, Catarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931601/ https://www.ncbi.nlm.nih.gov/pubmed/35311046 http://dx.doi.org/10.3389/fped.2022.816635 |
Ejemplares similares
-
Challenges in monitoring GnRH analog treatment in central precocious puberty
por: Latronico, Ana Claudia
Publicado: (2020) -
Gonadotropin-releasing hormone (GnRH) stimulation test before and after GnRH analogue treatment in central precocious puberty; can GnRH test simplify adequately?
por: Yang, You Jean, et al.
Publicado: (2013) -
Treatment of central precocious puberty using low dose GnRH analogs (GnRHa)
por: Jahagirdar, Rahul, et al.
Publicado: (2015) -
GnRH test for the diagnosis of central precocious puberty: is it time to
revisit the protocol ?
por: Sodero, Giorgio, et al.
Publicado: (2023) -
Evaluating the Efficacy of Treatment with a GnRH Analogue in Patients with Central Precocious Puberty
por: Kendirci, H. Nur Peltek, et al.
Publicado: (2015)